AKT1 and neoplasm: In addition, the activation of carcinogenic signaling pathways common in solid tumors, such as Ras and PI3K/AKT, and the inactivation of tumor suppressors, such as LKB1, PTEN, and TSC2/1, further exacerbate drug resistance by activating HIF-1 90, 91.